Increasing the dose and rate of Albunex infusion leads to superior left ventricular contrast effect.
In routine clinical use, the efficacy of Albunex in producing clinically useful opacification may be lower than in initial clinical studies. We hypothesized that increasing either the rate of injection or amount of Albunex administered would increase left ventricular opacification. Fifty adult volunteers were each injected with Albunex in five volume/rate combinations. Blinded reviewers evaluated left ventricular opacification and endocardial border delineation compared with the baseline (noncontrast) echocardiogram. In addition, captured digitized images were analyzed with video-densitometric techniques. Injected at the highest volume/rate tested (20 ml at 3.0 ml/sec), Albunex provided the greatest improvement in left ventricular opacification, endocardial border delineation, and quality of the echocardiogram. The administration of Albunex caused no serious adverse events at any volume/rate regimen tested. Our data indicate that faster injection rates and larger dose volumes than those currently recommended by the package insert significantly improve Albunex ultrasound contrast without compromising safety.
Dolan
M S
MS
Saint Louis University, Missouri, USA.
Dent
J
J
deFilippi
C
C
Christopher
T
T
Wible
J H
JH
Labovitz
A J
AJ
D000328:Adult; D000418:Albumins / Q000008:administration & dosage; D015331:Cohort Studies; D003287:Contrast Media / Q000008:administration & dosage*; D004452:Echocardiography / Q000379:methods*; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008863:Microspheres
D000418:Albumins; C060687:Albunex; D003287:Contrast Media